SARS-CoV-2 nucleocapsid (N) protein antibodies can be used to identify the serological response to natural infection in those who have previously rec…
Globally, Indigenous populations have been disproportionately impacted by pandemics. In Australia, though national infection rates with COVID-19 infe…
The eradication of smallpox is considered one of the greatest achievements of humankind, thanks to vaccination. The widespread availability of childh…
Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of inf…
The changing phenotype of coronarvirus disease 2019 (COVID-19) may quickly render guideline-recommended interventions obsolete. We developed a 40-que…
Our interdisciplinary team initiated a project to inform the COVID-19 vaccination programme. We developed a novel research co-creation approach to sh…
Personal protective equipment is essential to protect healthcare workers when exposed to aerosol-generating procedures in patients with airborne resp…
PICOBOO is a randomised, adaptive trial evaluating the immunogenicity, reactogenicity, and safety of COVID-19 booster strategies. Here, we present da…
Vaccination has been a cornerstone of public health, substantially reducing the global burden of infectious diseases, notably evident during the COVI…